Publications by authors named "Yi-Ju Wei"
Article Synopsis
- Ferroptosis is a new way that cells can die, caused by damage to their membranes when certain fats build up, especially when there's too much iron or stress.
- A group of helpers called solute carrier transporters (SLCs) help move important nutrients like sugar and proteins into the cells, which is important for controlling ferroptosis.
- The study explores how these SLCs can be targeted to help treat diseases like cancer by controlling ferroptosis better.
The role of Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA -M2BP) in the prediction of disease severity in nonalcoholic fatty liver disease (NAFLD) remains elusive. This study evaluated the performance of WFA -M2BP in predicting fibrosis in patients with NAFLD. A total of 80 patients with biopsy-proven nonalcoholic steatohepatitis (NASH) were enrolled.
View Article and Find Full Text PDFHepatic progenitor cells (HPCs) might be the origin of hepatocellular carcinoma. 1α,25-Dihydroxyvitamin D3 (1,25(OH)D) (VD3) has been documented as an anticancer agent for various cancers. However, the potential effect of VD3 on the proliferation and malignant transformation of HPCs induced by aflatoxin B1 (AFB1) has not been determined.
View Article and Find Full Text PDFArticle Synopsis
- Researchers investigated the effects of rhFL (recombinant Flt3 ligand) on mouse EL-4 lymphoma and C26 colon adenocarcinoma tumors to explore its potential in cancer immunotherapy.
- The study found that rhFL significantly delayed tumor growth and resulted in smaller tumors and larger spleens compared to control groups.
- Histological analysis showed increased infiltration of immune cells in rhFL-treated tumors, indicating a stimulated immune response against the cancers.*